Danve B, Lissolo L, Mignon M, Dumas P, Colombani S, Schryvers A B, Quentin-Millet M J
Pasteur Mérieux Sérums et Vaccins, Marcy l'Etoile, France.
Vaccine. 1993 Sep;11(12):1214-20. doi: 10.1016/0264-410x(93)90045-y.
Transferrin-binding proteins (Tbps) were affinity-isolated from group B Neisseria meningitidis strain B16B6 and used to raise specific antisera. Administration of the antisera to mice loaded with human transferrin before bacterial challenge significantly protected the animals from death. In active immunization studies, mice received three 25 micrograms injections of purified Tbps over a period of 28 days, 7 days after which they were challenged with N. meningitidis. The survival rate in immunized mice was much higher than in control groups. In both active and passive immunization experiments mice were protected against at least 100 LD50. A specific Tbp antiserum was highly bactericidal against the parent strain and against approximately half of the strains tested.
从B群脑膜炎奈瑟菌B16B6菌株中亲和分离出转铁蛋白结合蛋白(Tbps),并用于制备特异性抗血清。在细菌攻击前,给负载人转铁蛋白的小鼠注射抗血清,可显著保护动物免于死亡。在主动免疫研究中,小鼠在28天内接受三次25微克纯化Tbps注射,7天后用脑膜炎奈瑟菌攻击。免疫小鼠的存活率远高于对照组。在主动和被动免疫实验中,小鼠均受到保护,免受至少100个半数致死量(LD50)的攻击。一种特异性Tbp抗血清对亲本菌株以及约一半的测试菌株具有高度杀菌作用。